Your search history is turned on.
Date: January 9, 2015 Jurisdictions: British Columbia
KM_C364e-20150109145625 ...
Date: January 6, 2015 Jurisdictions: British Columbia
KM_C364e-20150106180438 ...
Date: December 23, 2014 Jurisdictions: British Columbia
CELATOR PHARMACEUTICALS INC Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This report and other written reports and oral statements made from time to time by the Company may contain so-called forward- looking statements, all of which are b...
CELATOR PHARMACEUTICALS INC Exhibit 31.2 Certification of Chief Financial Officer Pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a) I, Fred M. Powell, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Celator Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue stat...
CELATOR PHARMACEUTICALS INC Exhibit 31.1 Certification of Chief Executive Officer Pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a) I, Scott T. Jackson, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Celator Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue st...
CELATOR PHARMACEUTICALS INC CELATOR PHARMACEUTICALS INC FORM 10-Q (Quarterly Report) Filed 11/13/14 for the Period Ending 09/30/14 Address 303B COLLEGE ROAD EAST PRINCETON, NJ 08540 Telephone (609) 243-0123 CIK 0001327467 Symbol CPXX SIC Code 2834 - Pharmaceutical Preparations Fiscal Year 12/31 http://www.edgar-online.com Copyright 2014,...
CELATOR PHARMACEUTICALS INC CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This report and other written reports and oral statements made from time to time by the Company may contain so-called forward- looking statements, all of which are based on managements current expectations and are subject to risks and uncertainties that may ca...
CELATOR PHARMACEUTICALS INC Exhibit 31.2 Certification of Chief Financial Officer Pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a) I, Fred M. Powell, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Celator Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue state...
CELATOR PHARMACEUTICALS INC Exhibit 31.1 Certification of Chief Executive Officer Pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a) I, Scott T. Jackson, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Celator Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement...
CELATOR PHARMACEUTICALS INC CELATOR PHARMACEUTICALS INC FORM 10-Q (Quarterly Report) Filed 08/07/14 for the Period Ending 06/30/14 Address 303B COLLEGE ROAD EAST PRINCETON, NJ 08540 Telephone (609) 243-0123 CIK 0001327467 Symbol CPXX SIC Code 2834 - Pharmaceutical Preparations Fiscal Year 12/31 http://www.edgar-online.com Copyright 2014,...